0 XP   0   0   0

COLINZ LABORATORIES LTD.
Buy, Hold or Sell?

Should you buy, hold or sell COLINZ LABORATORIES LTD.?

I guess you are interested in COLINZ LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse COLINZ LABORATORIES LTD.

Let's start. I'm going to help you getting a better view of COLINZ LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is COLINZ LABORATORIES LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how COLINZ LABORATORIES LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value COLINZ LABORATORIES LTD.. The closing price on 2023-02-03 was INR39.85 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
COLINZ LABORATORIES LTD. Daily Candlestick Chart
COLINZ LABORATORIES LTD. Daily Candlestick Chart
Summary









1. Valuation of COLINZ LABORATORIES LTD.




Current price per share

INR39.85

2. Growth of COLINZ LABORATORIES LTD.




Is COLINZ LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$937.8k$889.5k$48.3k5.2%

How much money is COLINZ LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$41.3k$25.3k$16k38.8%
Net Profit Margin4.9%3.4%--

How much money comes from the company's main activities?

3. Financial Health of COLINZ LABORATORIES LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of COLINZ LABORATORIES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit COLINZ LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare COLINZ LABORATORIES LTD. to the  industry mean.
  • A Net Profit Margin of 4.9% means that ₹0.05 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 4.9%. The company is making a profit. +1
  • The TTM is 4.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.9%0.0%
TTM4.9%YOY3.4%+1.5%
TTM4.9%5Y2.9%+2.0%
5Y2.9%10Y2.7%+0.2%
1.1.2. Return on Assets

Shows how efficient COLINZ LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare COLINZ LABORATORIES LTD. to the  industry mean.
  • 3.4% Return on Assets means that COLINZ LABORATORIES LTD. generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 3.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.4%0.0%
TTM3.4%YOY2.1%+1.4%
TTM3.4%5Y2.1%+1.3%
5Y2.1%10Y2.0%+0.1%
1.1.3. Return on Equity

Shows how efficient COLINZ LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare COLINZ LABORATORIES LTD. to the  industry mean.
  • 4.4% Return on Equity means COLINZ LABORATORIES LTD. generated ₹0.04 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 4.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY2.8%+1.6%
TTM4.4%5Y2.9%+1.5%
5Y2.9%10Y2.8%+0.1%

1.2. Operating Efficiency of COLINZ LABORATORIES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient COLINZ LABORATORIES LTD. is operating .

  • Measures how much profit COLINZ LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare COLINZ LABORATORIES LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y1.0%-1.0%
5Y1.0%10Y1.1%-0.1%
1.2.2. Operating Ratio

Measures how efficient COLINZ LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.27 means that the operating costs are ₹1.27 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 1.274. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.274. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.274TTM1.2740.000
TTM1.274YOY1.332-0.057
TTM1.2745Y1.128+0.146
5Y1.12810Y1.001+0.127

1.3. Liquidity of COLINZ LABORATORIES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if COLINZ LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 3.72 means the company has ₹3.72 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 3.724. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.724. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.724TTM3.7240.000
TTM3.724YOY2.813+0.911
TTM3.7245Y3.190+0.534
5Y3.19010Y3.074+0.116
1.3.2. Quick Ratio

Measures if COLINZ LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare COLINZ LABORATORIES LTD. to the  industry mean.
  • A Quick Ratio of 4.81 means the company can pay off ₹4.81 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 4.810. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.810. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.810TTM4.8100.000
TTM4.810YOY3.583+1.227
TTM4.8105Y3.403+1.407
5Y3.40310Y3.079+0.324

1.4. Solvency of COLINZ LABORATORIES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of COLINZ LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare COLINZ LABORATORIES LTD. to industry mean.
  • A Debt to Asset Ratio of 0.23 means that COLINZ LABORATORIES LTD. assets are financed with 22.6% credit (debt) and the remaining percentage (100% - 22.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 0.226. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.226. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.226TTM0.2260.000
TTM0.226YOY0.278-0.052
TTM0.2265Y0.256-0.030
5Y0.25610Y0.267-0.012
1.4.2. Debt to Equity Ratio

Measures if COLINZ LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare COLINZ LABORATORIES LTD. to the  industry mean.
  • A Debt to Equity ratio of 29.2% means that company has ₹0.29 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 0.292. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.292. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.292TTM0.2920.000
TTM0.292YOY0.386-0.094
TTM0.2925Y0.346-0.054
5Y0.34610Y0.368-0.023

2. Market Valuation of COLINZ LABORATORIES LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings COLINZ LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare COLINZ LABORATORIES LTD. to the  industry mean.
  • A PE ratio of 37.25 means the investor is paying ₹37.25 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of COLINZ LABORATORIES LTD.:

  • The EOD is 53.685. Good. +1
  • The MRQ is 37.250. Good. +1
  • The TTM is 37.250. Good. +1
Trends
Current periodCompared to+/- 
EOD53.685MRQ37.250+16.436
MRQ37.250TTM37.2500.000
TTM37.250YOY31.423+5.826
TTM37.2505Y27.704+9.545
5Y27.70410Y30.894-3.189
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of COLINZ LABORATORIES LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of COLINZ LABORATORIES LTD.:

  • The MRQ is 22.789. Seems overpriced? -1
  • The TTM is 22.789. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ22.789TTM22.7890.000
TTM22.789YOY19.747+3.042
TTM22.7895Y40.074-17.285
5Y40.07410Y40.0740.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of COLINZ LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 1.64 means the investor is paying ₹1.64 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of COLINZ LABORATORIES LTD.:

  • The EOD is 2.370. Good. +1
  • The MRQ is 1.644. Good. +1
  • The TTM is 1.644. Good. +1
Trends
Current periodCompared to+/- 
EOD2.370MRQ1.644+0.725
MRQ1.644TTM1.6440.000
TTM1.644YOY0.895+0.749
TTM1.6445Y0.765+0.879
5Y0.76510Y0.807-0.041
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of COLINZ LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8670.8670%0.992-13%-0.317+137%2.803-69%
Book Value Growth--1.0541.0540%1.066-1%1.034+2%1.034+2%
Book Value Per Share--16.81816.8180%15.951+5%16.349+3%16.691+1%
Book Value Per Share Growth--1.0541.0540%1.066-1%0.988+7%0.988+7%
Current Ratio--3.7243.7240%2.813+32%3.190+17%3.074+21%
Debt To Asset Ratio--0.2260.2260%0.278-19%0.256-12%0.267-15%
Debt To Equity Ratio--0.2920.2920%0.386-24%0.346-16%0.368-21%
Dividend Per Share----0%-0%-0%-0%
Eps--0.7420.7420%0.454+63%0.480+55%0.466+59%
Eps Growth--1.6351.6350%1.591+3%1.177+39%1.177+39%
Free Cash Flow Per Share--0.9400.9400%4.376-79%1.514-38%1.280-27%
Free Cash Flow Per Share Growth--0.2150.2150%3.726-94%3.242-93%3.242-93%
Free Cash Flow To Equity Per Share--1.1371.1370%4.551-75%1.629-30%1.364-17%
Free Cash Flow To Equity Per Share Growth--0.2500.2500%3.475-93%6.673-96%6.673-96%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.727--------
Intrinsic Value_10Y_min--7.502--------
Intrinsic Value_1Y_max--0.928--------
Intrinsic Value_1Y_min--0.902--------
Intrinsic Value_3Y_max--2.747--------
Intrinsic Value_3Y_min--2.595--------
Intrinsic Value_5Y_max--4.517--------
Intrinsic Value_5Y_min--4.151--------
Net Profit Margin--0.0490.0490%0.034+44%0.029+68%0.027+80%
Operating Margin----0%-0%0.010-100%0.011-100%
Operating Ratio--1.2741.2740%1.332-4%1.128+13%1.001+27%
Pb Ratio2.370+31%1.6441.6440%0.895+84%0.765+115%0.807+104%
Pe Ratio53.685+31%37.25037.2500%31.423+19%27.704+34%30.894+21%
Peg Ratio--22.78922.7890%19.747+15%40.074-43%40.074-43%
Price Per Share39.850+31%27.65027.6500%14.270+94%12.238+126%13.307+108%
Price To Total Gains Ratio45.987+31%31.90831.9080%14.379+122%-225.640+807%-180.309+665%
Profit Growth--1.6351.6350%1.591+3%1.292+27%1.292+27%
Quick Ratio--4.8104.8100%3.583+34%3.403+41%3.079+56%
Return On Assets--0.0340.0340%0.021+66%0.021+60%0.020+69%
Return On Equity--0.0440.0440%0.028+55%0.029+54%0.028+60%
Revenue Growth--1.1321.1320%0.810+40%0.977+16%0.977+16%
Total Gains Per Share--0.8670.8670%0.992-13%-0.317+137%2.803-69%
Total Gains Per Share Growth--0.8730.8730%95.941-99%18.505-95%18.505-95%
Usd Book Value--937862.800937862.8000%889538.600+5%863996.900+9%852616.012+10%
Usd Book Value Change Per Share--0.0110.0110%0.012-13%-0.004+137%0.034-69%
Usd Book Value Per Share--0.2050.2050%0.195+5%0.199+3%0.204+1%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0090.0090%0.006+63%0.006+55%0.006+59%
Usd Free Cash Flow--52411.20052411.2000%244032.001-79%75218.014-30%62681.679-16%
Usd Free Cash Flow Per Share--0.0110.0110%0.053-79%0.018-38%0.016-27%
Usd Free Cash Flow To Equity Per Share--0.0140.0140%0.056-75%0.020-30%0.017-17%
Usd Price Per Share0.486+31%0.3370.3370%0.174+94%0.149+126%0.162+108%
Usd Profit--41394.60041394.6000%25324.638+63%25125.095+65%23806.856+74%
Usd Revenue--850852.400850852.4000%751394.950+13%887251.149-4%902999.043-6%
Usd Total Gains Per Share--0.0110.0110%0.012-13%-0.004+137%0.034-69%
 EOD+2 -3MRQTTM+0 -0YOY+20 -185Y+25 -1410Y+21 -18

3.2. Fundamental Score

Let's check the fundamental score of COLINZ LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1553.685
Price to Book Ratio (EOD)Between0-12.370
Net Profit Margin (MRQ)Greater than00.049
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.810
Current Ratio (MRQ)Greater than13.724
Debt to Asset Ratio (MRQ)Less than10.226
Debt to Equity Ratio (MRQ)Less than10.292
Return on Equity (MRQ)Greater than0.150.044
Return on Assets (MRQ)Greater than0.050.034
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of COLINZ LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.048
Ma 20Greater thanMa 5044.658
Ma 50Greater thanMa 10045.488
Ma 100Greater thanMa 20046.923
OpenGreater thanClose40.250
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets99,314
Total Liabilities22,440
Total Stockholder Equity76,874
 As reported
Total Liabilities 22,440
Total Stockholder Equity+ 76,874
Total Assets = 99,314

Assets

Total Assets99,314
Total Current Assets73,791
Long-term Assets73,791
Total Current Assets
Cash And Cash Equivalents 20,881
Short-term Investments 31,182
Net Receivables 12,059
Inventory 9,253
Other Current Assets 416
Total Current Assets  (as reported)73,791
Total Current Assets  (calculated)73,791
+/-0
Long-term Assets
Property Plant Equipment 18,618
Long-term Assets Other 213
Long-term Assets  (as reported)25,523
Long-term Assets  (calculated)18,831
+/- 6,692

Liabilities & Shareholders' Equity

Total Current Liabilities19,815
Long-term Liabilities2,625
Total Stockholder Equity76,874
Total Current Liabilities
Short-term Debt 4,845
Short Long Term Debt 4,845
Accounts payable 4,751
Other Current Liabilities 2,581
Total Current Liabilities  (as reported)19,815
Total Current Liabilities  (calculated)17,022
+/- 2,793
Long-term Liabilities
Long-term Liabilities Other 407
Long-term Liabilities  (as reported)2,625
Long-term Liabilities  (calculated)407
+/- 2,218
Total Stockholder Equity
Common Stock35,450
Retained Earnings 41,424
Total Stockholder Equity (as reported)76,874
Total Stockholder Equity (calculated)76,874
+/-0
Other
Capital Stock35,450
Cash And Equivalents31,182
Cash and Short Term Investments 52,063
Common Stock Shares Outstanding 4,571
Liabilities and Stockholders Equity 99,314
Net Invested Capital 81,719
Net Working Capital 53,976



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
96,748
95,900
91,749
88,109
101,026
99,314
99,314101,02688,10991,74995,90096,748
   > Total Current Assets 
53,480
55,467
56,407
58,439
72,747
73,791
73,79172,74758,43956,40755,46753,480
       Cash And Cash Equivalents 
12,258
16,143
17,178
21,838
13,947
20,881
20,88113,94721,83817,17816,14312,258
       Short-term Investments 
0
0
17,178
21,838
32,868
31,182
31,18232,86821,83817,17800
       Net Receivables 
14,978
16,923
16,983
15,044
12,977
12,059
12,05912,97715,04416,98316,92314,978
       Inventory 
21,605
19,681
18,985
16,911
12,465
9,253
9,25312,46516,91118,98519,68121,605
       Other Current Assets 
496
106
254
266
491
416
416491266254106496
   > Long-term Assets 
0
0
35,342
29,670
28,279
25,523
25,52328,27929,67035,34200
       Property Plant Equipment 
26,330
24,119
22,100
20,590
20,255
18,618
18,61820,25520,59022,10024,11926,330
       Long-term Assets Other 
0
0
0
0
0
213
21300000
> Total Liabilities 
31,525
28,392
23,325
19,733
28,113
22,440
22,44028,11319,73323,32528,39231,525
   > Total Current Liabilities 
21,461
21,159
17,863
16,081
25,861
19,815
19,81525,86116,08117,86321,15921,461
       Short-term Debt 
7,595
4,206
6,755
3,806
9,926
4,845
4,8459,9263,8066,7554,2067,595
       Short Long Term Debt 
0
0
6,755
3,806
9,926
4,845
4,8459,9263,8066,75500
       Accounts payable 
4,515
6,754
3,429
3,694
5,441
4,751
4,7515,4413,6943,4296,7544,515
       Other Current Liabilities 
2,024
2,005
1,455
1,311
712
2,581
2,5817121,3111,4552,0052,024
   > Long-term Liabilities 
0
0
5,462
3,651
2,252
2,625
2,6252,2523,6515,46200
       Long-term Liabilities Other 
0
0
0
0
0
407
40700000
> Total Stockholder Equity
65,222
67,509
68,425
68,377
72,913
76,874
76,87472,91368,37768,42567,50965,222
   Common Stock
35,441
35,441
35,441
35,441
35,450
35,450
35,45035,45035,44135,44135,44135,441
   Retained Earnings 
9,828
12,135
13,352
14,657
37,463
41,424
41,42437,46314,65713,35212,1359,828
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
4,730
4,710
4,409
3,056
0
0
003,0564,4094,7104,730



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue69,742
Cost of Revenue-22,985
Gross Profit46,75746,757
 
Operating Income (+$)
Gross Profit46,757
Operating Expense-65,892
Operating Income3,850-19,135
 
Operating Expense (+$)
Research Development-
Selling General Administrative29,030
Selling And Marketing Expenses-
Operating Expense65,89229,030
 
Net Interest Income (+$)
Interest Income755
Interest Expense-755
Net Interest Income9030
 
Pretax Income (+$)
Operating Income3,850
Net Interest Income903
Other Non-Operating Income Expenses-
Income Before Tax (EBT)4,8033,850
EBIT - interestExpense = -755
3,393
4,148
Interest Expense755
Earnings Before Interest and Taxes (ebit)-5,558
Earnings Before Interest and Taxes (ebitda)7,570
 
After tax Income (+$)
Income Before Tax4,803
Tax Provision-1,410
Net Income From Continuing Ops3,3933,393
Net Income3,393
Net Income Applicable To Common Shares3,393
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--903
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ENLT.TA
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENLT.TA.

ENLT.TA Daily Candlestick Chart
GBPEUR.FOREX
4 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPEUR.FOREX.

GBPEUR.FOREX Daily Candlestick Chart
NZDPHP.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDPHP.FOREX.

NZDPHP.FOREX Daily Candlestick Chart
NZDIDR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDIDR.FOREX.

NZDIDR.FOREX Daily Candlestick Chart
MYRGBP.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRGBP.FOREX.

MYRGBP.FOREX Daily Candlestick Chart
GBPMYR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPMYR.FOREX.

GBPMYR.FOREX Daily Candlestick Chart
GBPIDR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPIDR.FOREX.

GBPIDR.FOREX Daily Candlestick Chart
SGDGBP.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGDGBP.FOREX.

SGDGBP.FOREX Daily Candlestick Chart
GBPSGD.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPSGD.FOREX.

GBPSGD.FOREX Daily Candlestick Chart
CADNOK.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CADNOK.FOREX.

CADNOK.FOREX Daily Candlestick Chart
SVRT.TA
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVRT.TA.

SVRT.TA Daily Candlestick Chart
PHTM.TA
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHTM.TA.

PHTM.TA Daily Candlestick Chart
NICE.TA
5 hours ago

I found you a Golden Cross on the daily chart of NICE.TA.

NICE.TA Daily Candlestick Chart
NFTA.TA
5 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
ICB.TA
5 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ICB.TA.

ICB.TA Daily Candlestick Chart
FRSX.TA
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FRSX.TA.

FRSX.TA Daily Candlestick Chart
DCMA.TA
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DCMA.TA.

DCMA.TA Daily Candlestick Chart
ARD.TA
5 hours ago

I found you a Death Cross on the daily chart of ARD.TA.

ARD.TA Daily Candlestick Chart
MCRNT.TA
7 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart